Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial
===============================================================================================================================================================

* Kuimin Mei
* Shukui Qin
* Zhendong Chen
* Ying Liu
* Linna Wang
* Jianjun Zou